Day: September 3, 2025

Newest Bathroom Essential from the Creators of the #1 Way to #2 100% Plant-Based Fibers, Hypoallergenic, and Septic Safe SUMMIT, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced the launch of Squatty Potty Wipes, the Company’s flagship entry into the consumable products market. Squatty Potty wipes are now available for sale in the United States on Amazon.com and www.squattypotty.com. The wipes launched in the United Kingdom in late August 2025 are also available at Amazon.co.uk. Squatty Potty wipes are pH balanced, alcohol free, cruelty free (no animal testing), and safe for sensitive and eczema prone skin. Made with 100% plant-based fibers, Squatty Potty wipes leave you feeling fresh and clean, and are flushable and septic safe when flushed according to packaging...

Live moderated webcast on Thursday, September 4th at 4:00 PM ET Access the event here BOSTON and LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced that it will participate in the Virtual Investor Closing Bell Series on Thursday, September 4, 2025 at 4:00 PM ET. As part of the event, Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics will provide a corporate overview and discuss its innovative payload platform fueling a pipeline of next-generation ADCs designed with novel immuno-oncology payloads to address a wide range of cancer tumor targets. In addition to the moderated discussion, investors and interested parties will...

GLEN ALLEN, Va., Sept. 03, 2025 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it has been granted a 180 calendar day extension from The Nasdaq Stock Market LLC (“Nasdaq”) to regain compliance with the Nasdaq’s minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on Nasdaq (the “Minimum Bid Price Requirement”), following the expiration of the initial 180 calendar day period to regain compliance on September 1, 2025, which was initially granted on March 5, 2025. The Company now has until March 2, 2026 to meet the Minimum Bid Price Requirement set forth in Nasdaq...

New longer-term post hoc analysis results of responders (n=6)1 showed long-lasting, durable pain reduction of nearly 66%, or a mean 5.08 reduction on the VAS pain scale, in patients with severe pancreatic cancer pain 100% of responders (n=7) 1 showed zero opioid use at their 3-month post-procedure follow-up2 Quality of life markers further improved including sleep quality, energy level and ability to lead normal daily and leisure time activities and reduced tension, vomiting and constipation THE WOODLANDS, TX, Sept. 03, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced new longer-term post hoc data from its initial trial phase of its first-in-human study proof-of-concept evaluating the...

Peer-reviewed research proves that HydroGraph ultra-pure graphene offers cost-effective, reusable adsorption medium for wastewater purification VANCOUVER, British Columbia, Sept. 03, 2025 (GLOBE NEWSWIRE) — HydroGraph Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph”), a leading producer of ultra-pure graphene, today announced the publication of a peer-reviewed study that demonstrates the potential of using HydroGraph graphene as a scalable solution for industrial wastewater treatment. The study, published in FlatChem (Elsevier), confirms that HydroGraph’s graphene can remove 100% of six organic dyes from wastewater within 10 minutes. The global wastewater market is projected to reach $20.01 billion by 2025 and $28.95 billion by 2032 at a CAGR of 5.4%. Organic dyes are a major pollutant in local water sources, and wastewater is often...

Kennewick, WA, Sept. 03, 2025 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL) Vivos Inc filed a provisional patent No.: 63/873,014 – STERILE THERMOGELS Vivos Inc. is pleased to announce the successful validation of a new electron beam (E-Beam) sterilization process for our hydrogel, marking a culmination of nearly a year of testing and validation of a process that was only viable because of the unique characteristics of our hydrogel. The validation was carried out under ISO 11137 by an international medical device accredited organization. Vivos applies these same high standards to both human (Radiogel®) and animal (Isopet®) therapies. The E-Beam sterilization process is reproduceable and more reliable than our current filtration process, achieving a sterility assurance level of 10-6, which is the most rigorous sterility level;...

SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that IP Australia (the Australian Patent Office) has granted patent number 2020271839 to Silo’s research and licensing partner Columbia University for the invention titled “Prophylactic efficacy of serotonin 4 receptor agonists against stress” exclusively licensed to Silo by Columbia University. The patent reinforces protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD), originally developed by Columbia University. “This patent further strengthens our global IP portfolio for SPC-15, protecting its novel approach to preventing stress-induced disorders and enhancing...

Paris – September 3, 2025   Sodexo and EAT are pleased to announce a new partnership to advance healthier and more sustainable eating habits. As EAT’s exclusive partner from the food service industry, Sodexo is proud to bring its global expertise to translate cutting-edge science into practical, scalable solutions that make food choices good for the people and the planet accessible to all. The partnership is rooted in a shared commitment to promote and inspire healthier and more sustainable eating. It will be highlighted for the first time at the Stockholm Food Forum, taking place in Stockholm on October 3-4, 2025. For Sodexo, which serves more than 80 million consumers daily, partnering with EAT, a leading player in food system transformation, is a critical asset to encourage and accelerate the adoption of better food habits. For...

– Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) –– One of the largest randomized phase 3 studies in this patient population will encompass broadest range of patient types per AUA/SUO Guidelines – IRVINE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that it has completed enrollment in its Phase 3, randomized, open-label PIVOT-006 study comparing adjuvant intravesical cretostimogene grenadenorepvec versus surveillance following bladder tumor removal in patients with intermediate-risk non-muscle invasive bladder cancer (IR NMIBC). “Intermediate-risk NMIBC...

To Present Six Posters Featuring the Company’s Latest Product Innovations MARIETTA, Ga., Sept. 03, 2025 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced its schedule for the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place September 3-6 in Las Vegas, NV. SAWC remains a premier event for clinicians and industry professionals to explore the latest clinical evidence and innovations in advanced wound care. The Company will showcase its leading advanced wound care portfolio in the exhibit hall at booth 511. Sponsored Lunch SymposiumTitle: Change is Inevitable: Mastering the Art of Wound Healing in an Evolving LandscapeDate: Thursday, September 4, 2025Time: 11:40 – 1:10 p.m. PDTFaculty: Paul Kim, DPM, MS, FACFAS; Nicolas Mouawad, MD, MPH, MBA, DFSVS, FRCS, FACS, RPVI; Scott...